Kristina Lindemann/healthtalk.no
Feb 2, 2025, 18:18
Kristina Lindemann: Norwegian RWD of outcome in patients with advanced and recurrent endometrial cancer
Kristina Lindemann, Head of the Gynecological Oncology Center at Oslo University Hospital, shared an article on LinkedIn:
“We just published real-world data of outcome in patients with advanced and recurrrent endometrial cancer. Molecular classification is crucial for prognostication, also in patients with advanced disease!
Implementation is important for access to immunotherapy, screening for Lynch syndrome as well as potential de-escalation in patients with POLE mutated tumors in the RAINBO program.”
Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy.
Authors: Kristina Lindemann, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 8, 2025, 17:03
Jun 8, 2025, 16:53